Photo: Associated Press By Peter Loftus   The Wall Street Journal CANCEL Biography @Loftus [email protected] July 13, 2015 4:47 p.m. ET 0 COMMENTS An experimental Roche Holding AG RHHBY […]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab (MPDL3280A; […]

One U.S. biotech company is celebrating Independence Day weekend with a fresh $1 billion in cash from a corporate partner, which it was able to secure without giving up its […]

Just when you think a biotech bear market is about to descend, the bulls come rushing in. News of a Greek default depressed markets yesterday and was only compounded by fears […]

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence […]

Immunovaccine and Incyte to Co-Fund Clinical Trial Combining DPX-Survivac and Epacadostat for Patients with Recurrent Disease HALIFAX, NOVA SCOTIA–(Marketwired – June 25, 2015) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) […]

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

VANCOUVER, BC–(Marketwired – June 01, 2015) – BriaCell Therapeutics Corp (TSX VENTURE: BCT) (“BriaCell“, the “Company”, or “BCT“) is pleased to announce that it has appointed Joseph Wagner, PhD as […]